[Evaluation of a method of chemosurgical treatment of malignant ovarian tumors].
Retrospectively, an efficacy of the two main variants of the primary combined therapy for serous cystadenocarcinoma was estimated: "surgery+chemotherapy" (552 patients) and "chemotherapy+surgery" (253 patients). Both variants resulted in rather high incidence (83.5% and 81.3%) of the clinical remission, but its duration was 14.4 months in the first group, and 7.6 months in the second. Also, there was some difference in the remote results of the treatment. It is concluded that there should be an individual approach to selecting the first step of the treatment taking account of the peculiarities of the organism and a course of the tumor process.